Literature DB >> 10215678

A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells.

F J Ehlert1, M T Griffin, G W Sawyer, R Bailon.   

Abstract

We describe a simple method for calculating the pharmacological activity of an agonist (A) relative to a standard agonist (S) using only the concentration-response curves of the two agonists. In most situations, we show that the product of the ratios of maximal responses (Emax - A/Emax - S) and potencies (EC50 - S/EC50 - A) is equivalent to the product of the affinity and intrinsic efficacy of A expressed relative to that of S. We refer to this term as the IRA value of A. In a cooperative system where the concentration-response curve of the standard agonist is steep and that of the test agonist is flatter with a lower maximal response, the simple calculation of IRA described above underestimates agonist activity; however, we also describe a means of correcting the IRA in this situation. We have validated our analysis with modeling techniques and have shown experimentally that the IRA values of muscarinic agonists for stimulating contractions in the guinea pig ileum (M3 response) are in excellent agreement with those measured in the phosphoinositide assay on Chinese hamster ovary cells expressing the M3 muscarinic receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215678

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  Muscarinic agonist potencies at three different effector systems linked to the M(2) or M(3) receptor in longitudinal smooth muscle of guinea-pig small intestine.

Authors:  H Okamoto; S A Prestwich; S Asai; T Unno; T B Bolton; S Komori
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

2.  Quantifying agonist activity at G protein-coupled receptors.

Authors:  Frederick J Ehlert; Hinako Suga; Michael T Griffin
Journal:  J Vis Exp       Date:  2011-12-26       Impact factor: 1.355

Review 3.  Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.

Authors:  Philip G Strange
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

4.  Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists.

Authors:  David Winpenny; Mellissa Clark; Darren Cawkill
Journal:  Br J Pharmacol       Date:  2016-03-01       Impact factor: 8.739

Review 5.  Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.

Authors:  P G Strange
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

6.  Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor.

Authors:  Andreas Bock; Brian Chirinda; Fabian Krebs; Regina Messerer; Julia Bätz; Mathias Muth; Clelia Dallanoce; Dominika Klingenthal; Christian Tränkle; Carsten Hoffmann; Marco De Amici; Ulrike Holzgrabe; Evi Kostenis; Klaus Mohr
Journal:  Nat Chem Biol       Date:  2013-11-10       Impact factor: 15.040

7.  Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias.

Authors:  Frederick J Ehlert; Michael T Griffin
Journal:  J Pharmacol Toxicol Methods       Date:  2014-01-13       Impact factor: 1.950

8.  A single binding site mediates resistance- and disease-associated activities of the effector protein NIP1 from the barley pathogen Rhynchosporium secalis.

Authors:  Klaas A E van't Slot; Angela Gierlich; Wolfgang Knogge
Journal:  Plant Physiol       Date:  2007-05-03       Impact factor: 8.340

9.  Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.

Authors:  John A Tran; Alexander Chang; Minoru Matsui; Frederick J Ehlert
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

10.  Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.

Authors:  Katherine W Figueroa; Michael T Griffin; Frederick J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  2008-09-29       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.